Ads
-
Related paper
- ANTI-INFECTION PEPTIDE LL37 SUSTAINED DELIVERY SYSTEM - A POTENTIAL NEW TREATMENT OF OCULAR INFECTIONS. REPORT2. ANTIVIRAL ACTIVITY OF LL37 INCAPSULATED IN SILICA NANOPARTICLES
- The sustained delivery system of the antiinfection peptide LL37 ? a potential new method of treatment of ocular infections. Report 3. Antimicrobial activity of LL37 encapsulated in silica nanoparticle
- THE SUSTAINED DELIVERY SYSTEM OF THE ANTI-INFECTION PEPTIDE LL37 SYSTEM - A POTENTIALLY NEW TREATMENT METHOD OF OCULAR INFECTIONS. REPORT 1. TESTING OF DIFFERENT NANOAND MICROPARTICLES AS CARRIERS OF LL37
- IN-SITU GEL SYSTEM BASED ON TEMPERATURE AND pH ACTIVATION FOR SUSTAINED OCULAR DELIVERY
- A Review of Potential Effect of Nanotechnology and Control Drug Delivery System Introduce Into Ocular Drug Delivery System
- Ocular Manifestations in Rheumatoid Arthritis and their Co-Relation with Anti Cyclic Citrullinated Peptide Antibodies
- TOPICAL CO-DELIVERY OF INDOMETHACIN AND NIGELLA SATIVA L. ESSENTIAL OIL IN POLY--CAPROLACTONE NANOPARTICLES: IN VIVO STUDY OF ANTI-INFLAMMATORY ACTIVITY
- Preparation and Characterization of Polymeric Nanoparticles for Sustained Delivery of Insulin
- Serum anti-cyclic citrullinated peptide antibodies before and after treatment by disease-modifying anti-rheumatic drugs
- Drug Delivery using Mesoporous Silica Nanoparticles